Gelteq Limited - Ordinary Shares (GELS)
1.9000
-0.4200 (-18.10%)
NASDAQ · Last Trade: Apr 27th, 7:11 PM EDT
Detailed Quote
Previous Close | 2.320 |
---|---|
Open | 2.320 |
Bid | 1.850 |
Ask | 2.000 |
Day's Range | 1.820 - 2.330 |
52 Week Range | 0.7701 - 5.500 |
Volume | 410,346 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 4,482,755 |
Chart
About Gelteq Limited - Ordinary Shares (GELS)
Gelteq Limited is a biotechnology company focused on the development and commercialization of innovative drug delivery systems and therapeutic solutions. The company specializes in utilizing advanced technologies to formulate and manufacture complex pharmaceuticals, aiming to enhance the efficacy and safety of treatments. Gelteq's research initiatives are dedicated to addressing unmet medical needs across various therapeutic areas, and the company collaborates with healthcare professionals and institutions to bring its cutting-edge products to market. Through its commitment to scientific excellence and patient-centered solutions, Gelteq strives to improve patient outcomes and transform healthcare delivery. Read More
News & Press Releases
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
Via Chartmill · April 25, 2025
Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.
Via Chartmill · April 23, 2025
Via Benzinga · April 23, 2025
Via Benzinga · April 23, 2025
Via Benzinga · April 23, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · April 22, 2025
A wave of groundbreaking announcements this week has put the spotlight on several micro- and small-cap innovators shaping the future of healthcare, biotech, and clean energy—earning high-level regulatory, federal, and commercial support.
Via AB Newswire · April 22, 2025
Via Benzinga · April 22, 2025
Via Benzinga · April 22, 2025
Via Benzinga · April 22, 2025
Via Benzinga · April 22, 2025
Via Benzinga · March 28, 2025
Via Benzinga · March 24, 2025
Via Benzinga · March 21, 2025

Via Benzinga · January 28, 2025

Via Benzinga · December 10, 2024

Via Benzinga · December 10, 2024

Via Benzinga · December 3, 2024

Via Benzinga · December 3, 2024

Heritage Distilling, Ming Shing, and Dynamix all made a public debut as the IPO market has cooled off ahead of Thanksgiving week in the U.S.
Via Talk Markets · November 24, 2024